Treatment-driven peripheral blood transcriptomic remodelling and baseline predictors of ESSDAI and STAR response to B-cell therapy in Sj&#246;gren&#39;s disease.

Benlysta (belimumab) - GSK

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42781881

Aimen Ibrahim; Andre van Maurik; Coziana Ciurtin; Eileen Tian; Elizabeth C Jury; John Casement; Junjie Peng; Kyle Thompson; Lucia Martin-Gutierrez; Wan-Fai Ng

Sep 25, 2026